66 patents currently held
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next US patent term in the Thermolife International, LLC portfolio ends in Dec 2027, and more of its terms end in 2027 (33) than in any other year. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
40
Ending by 2030
Dec 2027
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2027 · High confidence
Also notable
Ends Sep 2040 · High confidence
Also notable
Ends Mar 2039 · High confidence
Also notable
Ends Jun 2040 · High confidence
Also notable
Ends Dec 2034 · High confidence
Also notable
Ends Jun 2032 · High confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Sep 2038 · High confidence
Amino Acid Compositions
US 8,466,187
Cited by 61 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Hexylamine Salts and Methods of Using Hexylamine
US 11,541,020
Cited by 6 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2040.
Creatine And/Or Creatinine Compositions and Related Methods
US 11,154,499
A family of 5 related applications built on the 2021 grant. Protection runs to 2039.
Compositions for Creatine Supplementation in Creatine Non-Responders
US 11,260,096
Cited by 6 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2040.
Salts of Carnitine Derivatives and Methods of Production
US 9,573,883
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2034.
N-Acetyl Beta Alanine Methods of Use
US 8,802,731
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2032.
Glutaurine Compositions and Therapeutic Uses Thereof
US 10,420,739
Granted 2019. Computed term ends 2033.
Enriched Root Powder Products and Methods of Producing Thereof
US 10,702,796
Granted 2020. Computed term ends 2038.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 24, 2027The maintenance fee for Glutaurine Compositions and Therapeutic Uses Thereof (US 10,420,739) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
- 3 fees due Apr 1 to 8, 2027 · next Apr 1
- 3 fees due May 12 to 26, 2027 · next May 12
- 1 fee due Jul 9, 2027The maintenance fee for Method of Treating Migraines and Headaches (US 11,865,139) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
Recent changes
- 5 of the patents on this record were granted since Aug 24, 2026
What they patent
The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Amino Acid Compounds | 38 in force | to Jan 2029 |
| Hexylamine Salts and Methods of Using Hexylamine | 4 in force | to Sep 2040 |
| Methods of Increasing Blood Oxygen Saturation | 3 in force | to Nov 2041 |
| Creatine And/Or Creatinine Compositions and Related Methods | 3 in force | to Mar 2039 |
| Glutaurine Compositions and Therapeutic Uses Thereof | 3 in force | to Jun 2033 |
| Method of Producing Decolorized Beet Products and Compositions Produced Therefrom | 2 in force | to Mar 2040 |
| Enriched Root Powder Products and Methods of Producing Thereof | 2 in force | to Sep 2038 |
| Salts of Carnitine Derivatives and Methods of Production | 2 in force | to Dec 2034 |
| N-Acetyl Beta Alanine Methods of Use | 2 in force | to Jun 2032 |
| Ecdysterone Compounds | 2 in force | to Jul 2029 |
| Soluble Curcumin and Its Derivatives | 1 in force | to Jun 2044 |
| Iron Supplement Compositions and Methods of Use Thereof | 1 in force | to Aug 2042 |
| Compositions for Creatine Supplementation in Creatine Non-Responders | 1 in force | to Jun 2040 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,569,368 | Amino Acid Compounds In force · High confidence | In force | High confidence | |
| US 8,569,369 | Amino Acid Compounds In force · High confidence | In force | High confidence | |
| US 8,952,045 | Amino Acid Compositions In force · High confidence | In force | High confidence | |
| US 8,952,046 | Amino Acid Compositions In force · High confidence | In force | High confidence | |
| US 8,952,047 | Betaine Compounds In force · High confidence | In force | High confidence | |
| US 8,957,100 | Amino Acid Compositions In force · High confidence | In force | High confidence | |
| US 8,957,101 | Amino Acid Compositions In force · High confidence | In force | High confidence | |
| US 10,426,750 | Amino Acid Supplement Formulations In force · High confidence | In force | High confidence | |
| US 10,426,792 | Amino Acid Compositions In force · High confidence | In force | High confidence | |
| US 10,435,356 | Amino Acid Compositions In force · High confidence | In force | High confidence |
Also on record, not counted in the 66: 1 patent in force now held by others · 1 patent ended · 44 applications pending · 27 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.